Ligand Pharmaceuticals Inc. LGND reported third-quarter 2017 adjusted earnings of ... Ligand’s shares have outperformed the industry year to date. The stock has soared 42.5% compared with the industry’s 2.7% increase. View photos Total …
Ligand Pharmaceuticals Inc. (LGND) reported second quarter EPS of $0.67 after the bell Monday, up from $0.35 in the prior year period. Ligand Pharmaceuticals gapped open higher Tuesday and spiked to the upside in early trade. The stock …
Ligand Pharmaceuticals Incorporated LGND announced that it has entered into a worldwide ... Ligand's three month share price movement shows that the stock has marginally outperformed the Zacks classified Medical - Biomedical and …
Ligand Pharmaceuticals Incorporated LGND is scheduled to report second-quarter 2016 results on Aug 4 before the market opens. In the last reported quarter, Ligand had posted a positive earnings surprise of 67.39%. Let’s see how things are …
Ligand Pharmaceuticals Incorporated LGND reported third-quarter 2016 earnings of 39 cents ... timing of funding of internal development programs and stock-based compensation expense. General & administrative expenses were up 26.8% …